Equillium Announces Initiation of the EQUALISE Phase 1b Clinical Trial of Itolizumab for Patients with Lupus Nephritis and Provides Business UpdateGlobeNewsWire • 10/01/19
Equillium to Present at H. C. Wainwright 21st Annual Global Investment ConferenceGlobeNewsWire • 08/27/19